Skin substitutes for the management of mohs micrographic surgery wounds: a systematic review.
Kimberly W LuAmor KhachemounePublished in: Archives of dermatological research (2022)
The data on skin substitute usage for managing Mohs micrographic surgery (MMS) wounds remain limited. This systematic review aimed to provide an overview of skin substitutes employed for MMS reconstruction, summarize clinical characteristics of patients undergoing skin substitute-based repair after MMS, and identify advantages and limitations of skin substitute implementation. A systematic review of Ovid MEDLINE, EMBASE, Cochrane Library, and Web of Science databases, from inception to April 7, 2021, identified all cases of MMS defects repaired using skin substitutes. A total of 687 patients were included. The mean patient age was 70 years (range: 6-98 years). Commonly used skin substitutes were porcine collagen (n = 397), bovine collagen (n = 78), Integra (n = 53), Hyalofill (n = 43), amnion/chorion-derived grafts (n = 40), and allogeneic epidermal-dermal composite grafts (n = 35). Common factors influencing skin substitute selection were cost, healing efficacy, cosmetic outcome, patient comfort, and ease of use. Some articles did not specify patient and wound characteristics. Skin substitute usage in MMS reconstruction is not well-guided. Blinded randomized control trials comparing the efficacy of skin substitutes and traditional repair methods are imperative for establishing evidence-based guidelines on skin substitute usage following MMS.
Keyphrases
- wound healing
- soft tissue
- systematic review
- patients undergoing
- healthcare
- minimally invasive
- bone marrow
- primary care
- randomized controlled trial
- ejection fraction
- clinical trial
- acute coronary syndrome
- stem cell transplantation
- coronary artery bypass
- newly diagnosed
- coronary artery disease
- clinical practice
- artificial intelligence
- surgical site infection